☆ 4.7 Review

New-Onset Diabetes After COVID-19

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2023)

Related references

Note: Only part of the references are listed.

Article Endocrinology & Metabolism

Relation of Incident Type 1 Diabetes to Recent COVID-19 Infection: Cohort Study Using e-Health Record Linkage in Scotland

Paul M. M. McKeigue et al.

Summary: Using national register data and virology laboratory data, this study found that there was no association between SARS-CoV-2 infection and an increase in the incidence of type 1 diabetes. Although there was an increase in type 1 diabetes incidence in children during the pandemic, it was not caused by SARS-CoV-2 infection.

DIABETES CARE (2023)

Add to Collection

Article Medicine, General & Internal

Risk of autoimmune diseases in patients with COVID-19: a retrospective cohort study

Renin Chang et al.

Summary: This retrospective cohort study reveals that there is a significant association between COVID-19 and the risk of autoimmune diseases. However, further research is needed to replicate these findings in an independent dataset and understand the underlying mechanisms.

ECLINICALMEDICINE (2023)

Add to Collection

Article Immunology

Changes in Population Immunity Against Infection and Severe Disease From Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Omicron Variants in the United States Between December 2021 and November 2022

Fayette Klaassen et al.

Summary: Despite the widespread exposure to SARS-CoV-2 in the US, the level of population immunity has evolved due to waning protection and additional infections and vaccinations. Using a Bayesian model, the study estimates the immunity against Omicron variants by location and week, showing a substantial increase in protection against infection and severe disease from December 2021 to November 2022.

CLINICAL INFECTIOUS DISEASES (2023)

Add to Collection

Letter Medicine, General & Internal

SARS-CoV-2 Infection and Presymptomatic Type 1 Diabetes Autoimmunity in Children and Adolescents

Renin Chang

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2023)

Add to Collection

Letter Medicine, General & Internal

SARS-CoV-2 Infections and Presymptomatic Type 1 Diabetes Autoimmunity in Children and Adolescents-Reply

Marian Rewers et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2023)

Add to Collection

Review Medicine, General & Internal

Outcomes after Critical Illness

Margaret S. Herridge et al.

Summary: Outcomes after critical illness can have a profound impact on the entire family. The authors provide a summary of data regarding these outcomes and emphasize the importance of viewing ICU care as part of a continuum of treatment for critically ill patients.

NEW ENGLAND JOURNAL OF MEDICINE (2023)

Add to Collection

Article Medicine, General & Internal

Association of Treatment With Nirmatrelvir and the Risk of Post-COVID-19 Condition

Yan Xie et al.

Summary: This cohort study found that treatment with nirmatrelvir within 5 days of a positive SARS-CoV-2 test result was associated with reduced risk of post-COVID-19 condition (PCC) in individuals with SARS-CoV-2 infection who had at least 1 risk factor for progression to severe disease.

JAMA INTERNAL MEDICINE (2023)

Add to Collection

Article Endocrinology & Metabolism

Comparative Incidence of Diabetes Following Hospital Admission for COVID-19 and Pneumonia: A Cohort Study

Naomi Holman et al.

Summary: This study aimed to investigate whether COVID-19 increases the incidence of diabetes. The results showed that COVID-19 did not have a significant impact on the incidence of diabetes compared to people hospitalized with pneumonia.

DIABETES CARE (2023)

Add to Collection

Article Endocrinology & Metabolism

Classification and Diagnosis of Diabetes: Standards of Care in Diabetes-2023

Nuha A. ElSayed et al.

DIABETES CARE (2023)

Add to Collection

Article Endocrinology & Metabolism

The Incidence of Diabetes Among 2,777,768 Veterans With and Without Recent SARS-CoV-2 Infection

Pandora L. Wander et al.

Summary: This study found that SARS-CoV-2 infection is associated with a higher risk of incident diabetes in men, but not in women, even after accounting for hospital surveillance.

DIABETES CARE (2022)

Add to Collection

Article Endocrinology & Metabolism

Incidence of Type 1 Diabetes in Children and Adolescents During the COVID-19 Pandemic in Germany: Results From the DPV Registry

Clemens Kamrath et al.

Summary: The study found a significant increase in the incidence of type 1 diabetes in children during the COVID-19 pandemic in Germany, with the peak incidence of diabetes occurring approximately 3 months after the peak of the COVID-19 pandemic. The underlying causes are yet unknown, but more likely to be indirect effects of the pandemic rather than direct effects.

DIABETES CARE (2022)

Add to Collection

Letter Endocrinology & Metabolism

Risk of new-onset type 2 diabetes in 600 055 people after COVID-19: A cohort study

Morgan Birabaharan et al.

DIABETES OBESITY & METABOLISM (2022)

Add to Collection

Article Endocrinology & Metabolism

No Evidence of Long-Term Disruption of Glycometabolic Control After SARS-CoV-2 Infection

Andrea Laurenzi et al.

Summary: This study aimed to assess whether dysglycemia diagnosed during COVID-19 pneumonia could become a potential public health problem after the infection is resolved. The research found that COVID-19-associated dysglycemia is unlikely to be a lasting public health problem, thereby cautioning against alarmist claims on the risk of diabetes after COVID-19 pneumonia.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2022)

Add to Collection

Article Endocrinology & Metabolism

Newly diagnosed diabetes vs. pre-existing diabetes upon admission for COVID-19: Associated factors, short-term outcomes, and long-term glycemic phenotypes

Sara J. Cromer et al.

Summary: Newly diagnosed diabetes mellitus (NDDM) associated with COVID-19 is more common in younger patients and less common in non-Hispanic White race/ethnicity. NDDM is characterized by lower glucose levels and higher inflammatory markers. It is associated with lower insulin requirements, longer length of stay, and intensive care unit admission, but not with death. Approximately half of NDDM patients experience regression of diabetes.

JOURNAL OF DIABETES AND ITS COMPLICATIONS (2022)

Add to Collection

Review Infectious Diseases

A clinical case definition of post-COVID-19 condition by a Delphi consensus

Joan B. Soriano et al.

Summary: People with COVID-19 might experience long-term symptoms known as long COVID or long-haul COVID. The lack of a standardized definition hinders the understanding and treatment of this condition. In a WHO-led Delphi process, a consensus definition was developed, stating that post-COVID-19 condition occurs in individuals with a history of SARS-CoV-2 infection, with symptoms lasting for at least 2 months and impacting everyday functioning. This common framework provides a foundation for future studies and therapy.

LANCET INFECTIOUS DISEASES (2022)

Add to Collection

Article Cell Biology

Limited extent and consequences of pancreatic SARS-CoV-2 infection

Verena van der Heide et al.

Summary: In this study, comprehensive single-cell analysis of SARS-CoV-2-infected human pancreatic islets revealed that the infection is strictly dependent on the ACE2 receptor and targets various pancreatic cell types. However, the infection is limited and non-cytopathic, causing only mild cellular perturbations and inflammatory responses. Similar outcomes were observed with endemic coronaviruses. Further evaluation is needed to determine if COVID-19-induced damage to the pancreas and immunological changes increase the risk of diabetes.

CELL REPORTS (2022)

Add to Collection

Article Endocrinology & Metabolism

Adipose tissue in COVID-19: detection of SARS-CoV-2 in adipocytes and activation of the interferon-alpha response

A. Basolo et al.

Summary: In fatal cases of COVID-19, a significant proportion of adipocytes have been found to contain the SARS-CoV-2 nucleocapsid antigen, indicating direct infection of subcutaneous fat cells by the virus. Infection seems to activate the IFN alpha pathway and attract infiltrating leukocytes. Due to the large numbers of adipocytes in adults, adipose tissue serves as a significant reservoir for SARS-CoV-2 and an important source of inflammatory mediators.

JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2022)

Add to Collection

Article Public, Environmental & Occupational Health

Risk for Newly Diagnosed Diabetes >30 Days After SARS-CoV-2 Infection Among Persons Aged

Catherine E. Barrett et al.

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2022)

Add to Collection

Article Endocrinology & Metabolism

COVID-19 pandemic and weight gain in American adults: A nationwide population-based study

Jagdish Khubchandani et al.

Summary: The study found that during the pandemic, 48% of individuals gained weight, 34% remained the same weight, and 18% lost weight. The largest proportion of weight gain occurred in individuals who were very overweight before the pandemic. Additionally, individuals with anxiety, depression, or symptoms of both tended to have a higher rate of weight gain.

DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS (2022)

Add to Collection

Article Endocrinology & Metabolism

Incidence of newly diagnosed diabetes after Covid-19

Wolfgang Rathmann et al.

Summary: This study investigated the incidence of diabetes after infection with Covid-19. The results showed that individuals with Covid-19 had an increased incidence of type 2 diabetes compared to those with acute upper respiratory tract infections (AURI). These findings support the active monitoring of glucose dysregulation after recovery from mild Covid-19.

DIABETOLOGIA (2022)

Add to Collection

Article Endocrinology & Metabolism

Characterizing progressive beta-cell recovery after new-onset DKA in COVID-19 provoked A-β plus KPD (ketosis-prone diabetes): A prospective study from Eastern India

Riddhi Das Gupta et al.

Summary: This study demonstrates progressive recovery of beta-cell secretion in new-onset A-beta + ketosis-prone diabetes (KPD) provoked by COVID-19 infection in Indian adults. These patients have a distinct profile from Type 1A diabetes. Meticulous follow-up involving C-peptide estimations can guide treatment and prevent unnecessary use of insulin.

JOURNAL OF DIABETES AND ITS COMPLICATIONS (2022)

Add to Collection

Article Cardiac & Cardiovascular Systems

FACTORS ASSOCIATED WITH WEIGHT GAIN DURING THE COVID-19 PANDEMIC

Ming Sum Lee et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2022)

Add to Collection

Article Endocrinology & Metabolism

Factors associated with weight gain during the COVID-19 pandemic

Jesse Goitia et al.

Summary: The study found that during the COVID-19 pandemic, 7.3% of adults experienced significant weight gain of 15 pounds or more. The most affected groups included young adults, individuals from low-income neighborhoods, and patients with depression.

OBESITY RESEARCH & CLINICAL PRACTICE (2022)

Add to Collection

Article Multidisciplinary Sciences

The associations between COVID-19 diagnosis, type 1 diabetes, and the risk of diabetic ketoacidosis: A nationwide cohort from the US using the Cerner Real-World Data

Fares Qeadan et al.

Summary: There is a significantly increased risk of new-onset T1D in patients diagnosed with COVID-19, and patients with pre-existing T1D have a significantly higher risk of developing DKA following a COVID-19 diagnosis.

PLOS ONE (2022)

Add to Collection

Article Endocrinology & Metabolism

Risks and burdens of incident diabetes in long COVID: a cohort study

Yan Xie et al.

Summary: This study found an increased risk and burden of incident diabetes and antihyperglycaemic use in people with COVID-19 in the post-acute phase compared to a contemporary control group. The risks and burdens of post-acute outcomes were related to the severity of the acute phase of COVID-19.

LANCET DIABETES & ENDOCRINOLOGY (2022)

Add to Collection

Article Multidisciplinary Sciences

SARS-CoV-2 infection and persistence in the human body and brain at autopsy

Sydney B. Stein et al.

Summary: This study provides new insights into the extent of COVID-19 infection in patients. It reveals that SARS-CoV-2 can be widely distributed throughout the body, including the brain, and can persist for up to 230 days, particularly in severe cases.

NATURE (2022)

Add to Collection

Article Biochemistry & Molecular Biology

Acute and postacute sequelae associated with SARS-CoV-2 reinfection

Benjamin Bowe et al.

Summary: A new analysis using US Department of Veterans Affairs databases showed that reinfection is associated with increased risk of all-cause mortality, hospitalization and a wide range of long COVID complications in individuals who have had SARS-CoV-2 compared to those with no reinfection.

NATURE MEDICINE (2022)

Add to Collection

Article Multidisciplinary Sciences

Association of COVID-19 with diabetes: a systematic review and meta-analysis

Paddy Ssentongo et al.

Summary: This study aimed to estimate the incidence of newly diagnosed diabetes in survivors of COVID-19. Meta-analysis of 8 studies revealed that COVID-19 was associated with a 66% higher risk of incident diabetes, and this risk was not influenced by age, sex, or study quality.

SCIENTIFIC REPORTS (2022)

Add to Collection

Letter Medicine, General & Internal

SARS-CoV-2 Infections and Presymptomatic Type 1 Diabetes Autoimmunity in Children and Adolescents From Colorado, USA, and Bavaria, Germany

Marian Rewers et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2022)

Add to Collection

Article Endocrinology & Metabolism

Changes in body weight, health behaviors, and mental health in adults with obesity during the COVID-19 pandemic

Jaime P. Almandoz et al.

Summary: Weight gain in adults with obesity during the COVID-19 pandemic is associated with higher baseline BMI, deteriorations in mental health, maladaptive eating behaviors, and less physical activity and sleep.

OBESITY (2022)

Add to Collection

Article Medicine, General & Internal

Cardiometabolic outcomes up to 12 months after COVID-19 infection. A matched cohort study in the UK

Emma Rezel-Potts et al.

Summary: The incidence of cardiovascular disease and diabetes mellitus increases in the acute and post-acute phases after COVID-19, but declines in the long-term phase. Short-term cardiovascular complications after COVID-19 mainly include pulmonary embolism, atrial arrhythmias, and venous thromboses.

PLOS MEDICINE (2022)

Add to Collection

Article Endocrinology & Metabolism

Clinical/biochemical characteristics and related outcomes in people with new-onset diabetes and COVID-19: experience from a single centre

Diego Munoz Moreno et al.

Summary: This study describes the clinical and analytical characteristics of 19 patients admitted to a Spanish tertiary hospital with COVID-19 infection and new-onset diabetes mellitus (DM). The majority of these patients had type 2 DM, which may have been unmasked by the COVID-19 infection. The patients showed a good evolution of diabetes after hospital discharge, with most of them having preserved pancreatic reserve.

PRACTICAL DIABETES (2022)

Add to Collection

Letter Medicine, General & Internal

Examination of Trends in Diabetes Incidence Among Children During the COVID-19 Pandemic in Ontario, Canada, From March 2020 to September 2021

Rayzel Shulman et al.

JAMA NETWORK OPEN (2022)

Add to Collection

Review Medicine, General & Internal

Impact of COVID-19 vaccination on the risk of developing long-COVID and on existing long-COVID symptoms: A systematic review

Kin Israel Notarte et al.

Summary: This systematic review investigates the association between COVID-19 vaccination and long-COVID symptoms. The findings suggest that vaccination is associated with reduced risks of long-COVID, with preliminary evidence showing that two doses are more effective than one dose. The impact of vaccination on people with existing long-COVID symptoms is still controversial.

ECLINICALMEDICINE (2022)

Add to Collection

Article Cell Biology

SARS-CoV-2 infection drives an inflammatory response in human adipose tissue through infection of adipocytes and macrophages

Giovanny J. Martinez-Colon et al.

Summary: This study found that adipocytes in COVID-19 autopsy cases were infected by SARS-CoV-2, accompanied by inflammatory infiltrate. The study also revealed that SARS-CoV-2 infected adipose tissue-resident macrophages and initiated inflammatory responses. These findings suggest that SARS-CoV-2 infection in adipose tissue could contribute to the severity of COVID-19 through viral replication and induction of inflammation.

SCIENCE TRANSLATIONAL MEDICINE (2022)

Add to Collection

Letter Medicine, General & Internal

Association of SARS-CoV-2 Infection With New-Onset Type 1 Diabetes Among Pediatric Patients From 2020 to 2021

Ellen K. Kendall et al.

JAMA NETWORK OPEN (2022)

Add to Collection

Review Medicine, General & Internal

Risk for newly diagnosed diabetes after COVID-19: a systematic review and meta-analysis

Ting Zhang et al.

Summary: There is an increased risk of new-onset diabetes after COVID-19 infection, especially within the first 3 months. Patients of all ages and genders are at higher risk for developing diabetes after COVID-19.

BMC MEDICINE (2022)

Add to Collection

Article Endocrinology & Metabolism

The Incidence of Diabetes Among 2,777,768 Veterans With and Without Recent SARS-CoV-2 Infection

Pandora L. Wander et al.

Summary: This study found that SARS-CoV-2 infection is associated with a higher risk of incident diabetes in men but not in women, even after accounting for hospital surveillance.

DIABETES CARE (2022)

Add to Collection

Article Virology

Impaired glucose metabolism in patients with diabetes, prediabetes, and obesity is associated with severe COVID-19

Stephen M. Smith et al.

Summary: The study analyzed clinical characteristics associated with severe COVID-19 in 184 hospitalized patients in Livingston, New Jersey, and found that diabetes was common among COVID-19 patients and severe disease was often accompanied by impaired glucose metabolism.

JOURNAL OF MEDICAL VIROLOGY (2021)

Add to Collection

Letter Endocrinology & Metabolism

Proportion of newly diagnosed diabetes in COVID-19 patients: A systematic review and meta-analysis

Thirunavukkarasu Sathish et al.

DIABETES OBESITY & METABOLISM (2021)

Add to Collection

Article Immunology

The SARS-CoV-2 as an instrumental trigger of autoimmunity

Arad Dotan et al.

Summary: This article emphasizes the association between COVID-19 and the development of multiple types of autoantibodies and autoimmune diseases in patients. It highlights the potential molecular resemblance between SARS-CoV-2 and host self-components, leading to hyper-stimulation of the immune system. Recognizing autoimmune manifestations of COVID-19 is crucial for managing the ongoing pandemic and its long-term consequences.

AUTOIMMUNITY REVIEWS (2021)

Add to Collection

Review Nutrition & Dietetics

Weight Gain Associated with COVID-19 Lockdown in Children and Adolescents: A Systematic Review and Meta-Analysis

Tu-Hsuan Chang et al.

Summary: The study revealed significant increases in body weight and BMI among school-age children and adolescents during lockdown, especially with the BMI of the general population significantly higher than before the pandemic. Additionally, the prevalence of obesity and overweight also showed an increasing trend.

NUTRIENTS (2021)

Add to Collection

Article Endocrinology & Metabolism

Impact of undiagnosed type 2 diabetes and pre-diabetes on severity and mortality for SARS-CoV-2 infection

Arsenio Vargas-Vazquez et al.

Summary: Undiagnosed type 2 diabetes, pre-diabetes, and de novo hyperglycemia are risk factors for critical COVID-19 outcomes. Early measurement of HbA1c is essential to assess individual risk considering the high rates of undiagnosed type 2 diabetes in Mexico.

BMJ OPEN DIABETES RESEARCH & CARE (2021)

Add to Collection

Article Cell Biology

SARS-CoV-2 infects human pancreatic β cells and elicits β cell impairment

Chien-Ting Wu et al.

Summary: There is evidence suggesting a complex relationship between COVID-19 and diabetes, with SARS-CoV-2 being able to directly induce beta cell killing and this effect being rescued by NRP1 inhibition.

CELL METABOLISM (2021)

Add to Collection

Article Cell Biology

SARS-CoV-2 infection induces beta cell transdifferentiation

Xuming Tang et al.

Summary: Recent clinical data suggest a correlation between COVID-19 and diabetes. This study found SARS-CoV-2 viral antigen in pancreatic beta cells, leading to the possibility of cell transdifferentiation. Infection with SARS-CoV-2 can cause changes in cell fate, providing new insights into the pathomechanisms of COVID-19.

CELL METABOLISM (2021)

Add to Collection

Article Multidisciplinary Sciences

Diverse functional autoantibodies in patients with COVID-19

Eric Y. Wang et al.

Summary: COVID-19 patients show increased autoantibody reactivities against immunomodulatory proteins, which may affect immune function and lead to different clinical outcomes.

NATURE (2021)

Add to Collection

Article Cell Biology

Hyperglycemia in acute COVID-19 is characterized by insulin resistance and adipose tissue infectivity by SARS-CoV-2

Moritz Reiterer et al.

Summary: The study found that hyperglycemia is common among patients with ARDS, and in patients with both ARDS and COVID-19, insulin resistance is the main cause of hyperglycemia. COVID-19 patients have lower levels of adiponectin, and SARS-CoV-2 may infect adipocytes, leading to dysfunction of adipose tissue.

CELL METABOLISM (2021)

Add to Collection

Article Multidisciplinary Sciences

Viral infiltration of pancreatic islets in patients with COVID-19

Charlotte Steenblock et al.

Summary: This study comprehensively analyzed pancreatic tissues from COVID-19 patients and found detectable SARS-CoV-2 viral infiltration in beta-cells, potentially contributing to metabolic dysregulation. Even in the absence of overt new-onset diabetes, viral infection of pancreatic beta-cells may lead to varying degrees of metabolic abnormalities.

NATURE COMMUNICATIONS (2021)

Add to Collection

Article Multidisciplinary Sciences

New-onset IgG autoantibodies in hospitalized patients with COVID-19

Sarah Esther Chang et al.

Summary: In hospitalized COVID-19 patients, approximately 50% have detectable autoantibodies primarily targeting autoantigens associated with rare disorders. Additionally, a subset of autoantibodies develop de novo following SARS-CoV-2 infection.

NATURE COMMUNICATIONS (2021)

Add to Collection

Article Medicine, Research & Experimental

SARS-CoV-2 infection of the pancreas promotes thrombofibrosis and is associated with new-onset diabetes

Mirza Muhammad Fahd Qadir et al.

Summary: Evidence suggests that SARS-CoV-2 infection may lead to pancreatic inflammation and fibrosis, potentially resulting in new-onset diabetes. Signs of SARS-CoV-2 infection were found in the pancreas of both monkeys and humans.

JCI INSIGHT (2021)

Add to Collection

Review Medicine, Research & Experimental

The intersection of COVID-19 and autoimmunity

Jason S. Knight et al.

Summary: Severe COVID-19 may be associated with inappropriate immune responses that can trigger or exacerbate autoimmunity. Research has shown that a subset of critical COVID-19 patients develop autoantibodies, suggesting a potential link between preexisting autoimmunity and severe disease. Additionally, functional autoantibodies have been identified in some individuals following SARS-CoV-2 infection, indicating the possibility of de novo autoimmunity being triggered by the virus.

JOURNAL OF CLINICAL INVESTIGATION (2021)

Add to Collection

Article Endocrinology & Metabolism

Acute and long-term disruption of glycometabolic control after SARS-CoV-2 infection

Laura Montefusco et al.

Summary: Patients with COVID-19 may experience hyperglycaemia, insulin resistance, and abnormal glucose metabolism, with these glycaemic abnormalities potentially persisting for at least 2 months after recovery. Further research into metabolic abnormalities in the context of long COVID is warranted.

NATURE METABOLISM (2021)

Add to Collection

Article Endocrinology & Metabolism

SARS-CoV-2 infects and replicates in cells of the human endocrine and exocrine pancreas

Janis A. Mueller et al.

Summary: The study shows that SARS-CoV-2 can infect and impact insulin secretion in human pancreatic cells, potentially contributing to metabolic dysregulation observed in COVID-19 patients.

NATURE METABOLISM (2021)

Add to Collection

Article Endocrinology & Metabolism

Newly diagnosed diabetes is associated with a higher risk of mortality than known diabetes in hospitalized patients withCOVID-19

Huiqing Li et al.

DIABETES OBESITY & METABOLISM (2020)

Add to Collection

Review Biochemistry & Molecular Biology

SARS-CoV-2 infection: The role of cytokines in COVID-19 disease

Victor J. Costela-Ruiz et al.

CYTOKINE & GROWTH FACTOR REVIEWS (2020)

Add to Collection

Article Endocrinology & Metabolism

Fasting blood glucose at admission is an independent predictor for 28-day mortality in patients with COVID-19 without previous diagnosis of diabetes: a multi-centre retrospective study

Sufei Wang et al.

DIABETOLOGIA (2020)

Add to Collection

Article Infectious Diseases

Clinical value of immune-inflammatory parameters to assess the severity of coronavirus disease 2019

Zhe Zhu et al.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2020)

Add to Collection

Article Endocrinology & Metabolism

Newly-diagnosed diabetes and admission hyperglycemia predict COVID-19 severity by aggravating respiratory deterioration

Gian Paolo Fadini et al.

DIABETES RESEARCH AND CLINICAL PRACTICE (2020)

Add to Collection

Article Multidisciplinary Sciences

Neuropilin-1 is a host factor for SARS-CoV-2 infection

James L. Daly et al.

SCIENCE (2020)

Add to Collection

Article Multidisciplinary Sciences

Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity

Ludovico Cantuti-Castelvetri et al.

SCIENCE (2020)

Add to Collection

Review Endocrinology & Metabolism

Obesity in patients with COVID-19: a systematic review and meta-analysis

Yi Huang et al.

METABOLISM-CLINICAL AND EXPERIMENTAL (2020)

Add to Collection

Review Medicine, General & Internal

Cytokine Storm

David C. Fajgenbaum et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Add to Collection

Article Endocrinology & Metabolism

SARS-CoV-2 Receptor Angiotensin I-Converting Enzyme Type 2 (ACE2) Is Expressed in Human Pancreatic β-Cells and in the Human Pancreas Microvasculature

Daniela Fignani et al.

FRONTIERS IN ENDOCRINOLOGY (2020)

Add to Collection

Article Endocrinology & Metabolism

Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition

Pouya Saeedi et al.

DIABETES RESEARCH AND CLINICAL PRACTICE (2019)

Add to Collection

Editorial Material Medicine, General & Internal

Making Neighborhood-Disadvantage Metrics Accessible - The Neighborhood Atlas

Amy J. H. Kind et al.

NEW ENGLAND JOURNAL OF MEDICINE (2018)

Add to Collection

Review Medicine, General & Internal

New-Onset Diabetes After Acute and Critical Illness: A Systematic Review

Chirag J. Jivanji et al.

MAYO CLINIC PROCEEDINGS (2017)

Add to Collection

Review Endocrinology & Metabolism

Viral infections in type 1 diabetes mellitus - why the β cells?

Anne Op de Beeck et al.

NATURE REVIEWS ENDOCRINOLOGY (2016)

Add to Collection

Article Public, Environmental & Occupational Health

Weight Change and Incident Diabetes: Addressing an Unresolved Issue

Monique A. M. Jacobs-van der Bruggen et al.

AMERICAN JOURNAL OF EPIDEMIOLOGY (2010)

Add to Collection

Article Endocrinology & Metabolism

A method of identifying and correcting miscoding, misclassification and misdiagnosis in diabetes: a pilot and validation study of routinely collected data

S. de Lusignan et al.

DIABETIC MEDICINE (2010)

Add to Collection

Review Immunology

The role of infections in autoimmune disease

A. M. Ercolini et al.

CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2009)

Add to Collection

Review Medicine, General & Internal

Stress hyperglycaemia

Kathleen M. Dungan et al.

LANCET (2009)

Add to Collection

Article Endocrinology & Metabolism

Impact of degree of obesity on surrogate estimates of insulin resistance

SH Kim et al.

DIABETES CARE (2004)

Add to Collection

Article Medicine, General & Internal

Measuring inconsistency in meta-analyses

JPT Higgins et al.

BMJ-BRITISH MEDICAL JOURNAL (2003)

Add to Collection

© Peeref 2019-2024. All rights reserved.